$RAPH Cashflow Statement | Understand Stock

$RAPH

$1.40 +$0.00 (0.0%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based payment in exchange for services
Non cash issuance costs (Note 7g)
Share-based compensation

Changes in:
Other current assets
Related parties
Other accounts payables and accrued expenses
Net cash used in operating activities
Purchase of fixed assets
Cash flows from investing activities
Purchase of fixed assets
Net cash provided by investing activities
Cash flows from financing activities
Receipt of a loan
Cash acquired in the reverse recapitalization
Proceeds from issuance of common stock and warrants
Net cash provided by financing activities

Change in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Issuance of shares for past services
Non cash supplement
Current assets (excluding cash and cash equivalents)
Current liabilities
Reverse recapitalization effect on equity
Cash acquired in connection with reverse recapitalization transaction
Issuance of shares for debt (Note 7q)
Issuance of shares for past services (Note 7e)
Non cash issuance costs
Exercise of warrants
Exercise of warrants (Note 7j)

Comments